Results 241 to 250 of about 48,370 (295)

The Diagnostic Accuracy of Procalcitonin, Soluble Urokinase-Type Plasminogen Activator Receptors, and C-Reactive Protein in Diagnosing Urinary Tract Infections in the Emergency Department-A Diagnostic Accuracy Study. [PDF]

J Clin Med
Hertz MA, Johansen IS, Rosenvinge FS, Brasen CL, Andersen ES, Heltborg A, Skovsted TA, Petersen ERB, Cartuliares MB, Nielsen SL, Mogensen CB, Skjøt-Arkil H.   +11 more
europepmc   +1 more source

Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR), Growth Differentiation Factor-15 (GDF-15), and Soluble C5b-9 (sC5b-9) Levels Are Significantly Associated with Endothelial Injury Indices in CAR-T Cell Recipients. [PDF]

Int J Mol Sci
Gavriilaki E, Demosthenous C, Evangelidis P, Bousiou Z, Batsis I, Vardi A, Mallouri D, Koravou EE, Spyridis N, Panteliadou A, Karavalakis G, Masmanidou M, Touloumenidou T, Papalexandri A, Poziopoulos C, Yannaki E, Sakellari I, Politou M, Papassotiriou I.   +18 more
europepmc   +1 more source

Synergy of urokinase-type plasminogen activator receptor isomer (D1D2) and integrin α5β1 causes malignant transformation of hepatic cells and the occurrence of liver cancer

, 2014
Yingqun Zhou, Xiaoping Lv, Shan Li, Bing Bai, Lingling Zhan   +4 more
openalex   +2 more sources

Diagnostic value of soluble urokinase-type plasminogen activator receptor in patients with acute coronary syndrome: A systematic review and meta-analysis. [PDF]

Cardiol J
Pruc M, Jannasz I, Swieczkowski D, Procyk G, Gasecka A, Rafique Z, Chirico F, Bragazzi NL, Jaguszewski MJ, Wysocki J, Szarpak L.   +10 more
europepmc   +1 more source

Soluble Urokinase-Type Plasminogen Activator Receptor in Comatose Survivors After Out-of-Hospital Cardiac Arrest Treated with Targeted Temperature Management. [PDF]

Ther Hypothermia Temp Manag
Bro-Jeppesen J, Grejs AM, Andersen O, Jeppesen AN, Duez C, Kirkegaard H.   +5 more
europepmc   +1 more source

Binding of the urokinase-type plasminogen activator to its cell surface receptor is inhibited by low doses of suramin.

, 1993
Niels Behrendt, Ebbe Rønne, Keld Danø
openalex   +1 more source

Expression of Urokinase-Type Plasminogen Activator and Type 1 Plasminogen Activator Inhibitor in Gastric Cancer with Subserosal Invasion. Predictive Significance for Recurrence in the Liver.

, 1995
Soichi Tomimatsu, Takashi Ichikura, Shoetsu Tamakuma   +2 more
openalex   +1 more source

Circulating miR-10b, soluble urokinase-type plasminogen activator receptor, and plasminogen activator inhibitor-1 as predictors of non-small cell lung cancer progression and treatment response. [PDF]

Cancer Biomark
Setiawan L, Setiabudy R, Kresno SB, Sutandyo N, Syahruddin E, Jovianti F, Nadliroh S, Mubarika S, Setiabudy R, Siregar NC.   +9 more
europepmc   +1 more source

Differential inhibition of soluble and cell surface receptor-bound single-chain urokinase by plasminogen activator inhibitor type 2. A potential regulatory mechanism.

, 1994
Bradford S. Schwartz
openalex   +1 more source